Issuer Free Writing Prospectus dated June 28, 2023
Filed Pursuant to Rule 433
Relating to the Preliminary Prospectus dated June 27, 2023 and
Registration Statement No. 333-271050
KODIAK GAS SERVICES, INC.
This free writing prospectus relates only to the shares of common stock described below and should be read together with the preliminary prospectus, subject to completion, dated June 27, 2023 (the “Preliminary Prospectus”), of Kodiak Gas Services, Inc. (the “Company”) relating to its initial public offering of common stock. The information in this free writing prospectus updates and supersedes the information in the Preliminary Prospectus to the extent that it is inconsistent therewith, or prepared based on assumptions that are inconsistent with the information below. All references to page numbers and captions correspond to the Preliminary Prospectus unless otherwise specified.
The following information updates the information contained in the preliminary prospectus.
Public Offering Price (per share): | $16.00 |
Common Stock Offered by Us: | 16,000,000 shares (or 18,400,000 shares if the underwriters exercise in full their option to purchase additional shares of common stock). |
Common Stock Outstanding After this Offering: | 75,000,000 shares (or 77,400,000 shares if the underwriters exercise in full their option to purchase additional shares of common stock). |
Use of Proceeds: | We will receive net proceeds from this offering of approximately $230.4 million after deducting estimated expenses and underwriting discounts and commissions payable by us. |
| We intend to use the net proceeds from this offering, together with the proceeds resulting from the Term Loan Derivative Settlement and borrowings under the ABL Facility, to repay $300 million of borrowings outstanding under the Term Loan and fees relating to the Term Loan Transaction. In addition, any net proceeds resulting from the exercise of the underwriters’ option to purchase additional shares will be used for general corporate purposes, which may include repayments of borrowings under the ABL Facility. See “Use of Proceeds.” |
The following restates the “Use of Proceeds” section in the Preliminary Prospectus.
USE OF PROCEEDS
We will receive net proceeds of approximately $230.4 million from the sale of the common stock by us in this offering after deducting estimated expenses and underwriting discounts and commissions payable by us. If the underwriters exercise their option to purchase additional shares in full, we estimate the net proceeds will be approximately $266.5 million after deducting estimated expenses and underwriting discounts and commissions payable by us.
The principal purposes of this offering are to increase our financial flexibility, create a public market for our common stock, and facilitate our future access to the capital markets.
We intend to use the net proceeds from this offering, together with the proceeds resulting from the Term Loan Derivative Settlement and borrowings under the ABL Facility, to repay $300 million of borrowings outstanding under the Term Loan and fees relating to the Term Loan Transaction. In addition, any net proceeds resulting from the exercise of the underwriters’ option to purchase additional shares will be used for general corporate purposes, which may include repayments of borrowings under the ABL Facility. The maturity date of the Term Loan is September 22, 2028. The interest rate on borrowings under the Term Loan was 11.73% and 10.67% as of March 31, 2023 and December 31, 2022, respectively.
The following restates the “Capitalization” section in the Preliminary Prospectus in order to reflect the application of the net proceeds as described in “Use of Proceeds.”
CAPITALIZATION
The following table sets forth our capitalization as of March 31, 2023:
| • | | on an actual basis; and |